Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer.
Saved in:
| Title: | Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer. |
|---|---|
| Authors: | Barron CC; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Megid TBC; Dr. Léon-Richard Oncology Centre, Vitalité Health Network, Moncton, NB E1C 8X3, Canada., Deng Y; Department of Biostatistics, University Health Network, Toronto, ON M5G 1X6, Canada., Sugumar V; Department of Medicine, University of Toronto, Toronto, ON M5S 3H2, Canada., Ladak S; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Mesci A; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada., Yan M; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada., Lukovic J; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON M5T 1P5, Canada., Krzyzanowska MK; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.; Division of Medical Oncology & Hematology, Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada., Sawka AM; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Division of Endocrinology, University Health Network and University of Toronto, Toronto, ON M5G 2C4, Canada., Mete O; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Department of Pathology, University Health Network, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5G 2C4, Canada., Ma LX; Endocrine Oncology Site Group, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada. |
| Source: | The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyag211 |
